文献速递胃肠外科围术期管理与 ERAS

mFI-5 预测胃癌胃切除术后结局:ACS-NSQIP 分析

Utility of the mFI-5 as a predictor of post-operative outcomes following gastrectomy for gastric cancer: an ACS-NSQIP analysis.
PubMed 文献 · Surg Endosc · 2024-07-24

该研究基于 ACS-NSQIP 数据库 2011–2021 年 7438 例胃癌胃切除患者,按 mFI-5 评分分为 0、1、≥2 三组,采用单因素和多因素 logistic 回归分析。结果显示 mFI-5 ≥2 是全并发症、严重并发症、肺炎、心肌梗死和 30 天再入院的独立预测因素,衰弱程度越高,不良结局风险越高。

要点

  • mFI-5 ≥2 是全并发症(OR 1.43)和严重并发症(OR 1.42)的独立预测因素。
  • mFI-5 评分越高,30 天死亡率、非计划插管和急性肾衰竭风险显著增加。
  • mFI-5 可用于术前识别高风险胃癌手术患者并辅助优化决策。

核心结论

  • mFI-5 评分升高与胃癌胃切除术后严重并发症风险增加相关。
  • mFI-5 有助于识别高风险患者并改善术前讨论与优化。

研究设计与样本

  • 回顾性队列研究,查询 ACS-NSQIP 数据库 2011–2021 年因胃癌行部分或全胃切除术的患者。
  • 共纳入 7438 例患者,按 mFI-5 评分分为 0 分(3032 例)、1 分(2805 例)和 ≥2 分(1601 例)三组。
  • 采用单因素分析和多因素 logistic 回归评估 mFI-5 与术后结局的关联。

主要发现

  • mFI-5 ≥2 是全并发症(OR 1.43,p < 0.001)、严重并发症(OR 1.42,p < 0.001)、肺炎(OR 1.43,p = 0.010)、心肌梗死(OR 2.91,p = 0.005)和 30 天再入院(OR 1.33,p = 0.008)的独立预测因素。
  • 与无衰弱患者相比,较高衰弱组非计划插管风险增加(OR 2.06 和 OR 2.47,p < 0.001),脱机失败风险增加(OR 1.68,p = 0.003 和 OR 2.00,p < 0.001)。
  • 较高衰弱组急性肾衰竭风险增加(OR 3.25,p = 0.003 和 OR 3.27,p = 0.005),30 天死亡风险增加(OR 1.73,p = 0.009 和 OR 1.94,p = 0.004)。
  • 较高衰弱组非家庭出院风险增加(OR 1.34,p = 0.001 和 OR 1.74,p < 0.001)。

临床怎么用

  • 术前可采用 mFI-5 评分对胃癌胃切除患者进行衰弱评估,识别高风险人群。
  • 对 mFI-5 ≥2 的患者,应加强术前讨论、患者及家属沟通和围术期优化。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Gastric cancer is the 5th most common malignancy worldwide. Surgical treatment for the disease can often be highly morbid, especially in elderly patients. The modified 5-item frailty index (mFI-5), a recently developed tool for assessing patient frailty, has been shown to be an effective predictor of post-operative outcomes in various surgical fields. This study aims to assess the utility of the mFI-5 in predicting adverse postoperative outcomes following gastrectomy for gastric cancer. METHODS: The National Surgical Quality Improvement Program (NSQIP) database was queried for patients who underwent partial or total gastrectomy for gastric cancer between 2011 and 2021. The mFI-5 score was calculated based on the presence of hypertension, congestive heart failure, diabetes mellitus, chronic obstructive pulmonary disease, and partially or fully dependent functional status. Patients were stratified into 3 groups according to mFI-5 score (mFI-5 = 0, mFI-5 = 1, mFI-5 ≥ 2). Univariate analysis and multivariate logistic regression were used to evaluate the association between mFI-5 score and post-operative outcomes. RESULTS: 7438 patients were identified (mFI-5 = 0: 3032, mFI-5 = 1: 2805, mFI-5 ≥ 2: 1601). mFI-5 ≥ 2 was an independent predictor of overall complications (OR 1.43, p < 0.001), serious complications (OR 1.42, p < 0.001), pneumonia (OR 1.43, p = 0.010), MI (OR 2.91, p = 0.005), and readmission within 30 days (OR 1.33, p = 0.008). Patients with higher frailty were more likely to experience unplanned intubation (OR 2.06, p < 0.001; OR 2.47, p < 0.001), failure to wean from the ventilator (OR 1.68, p = 0.003; OR 2.00, p < 0.001), acute renal failure (OR 3.25, p = 0.003; OR 3.27, p = 0.005), 30-day mortality (OR 1.73, p = 0.009; OR 1.94, p = 0.004), and non-home discharge (OR 1.34, p = 0.001; OR 1.74, p < 0.001) relative to non-frail patients. CONCLUSION: Higher frailty, as indicated by an increased mFI-5 score, raises the risk of serious post-operative complications in patients with gastric cancer undergoing gastrectomy. The mFI-5 has the potential to help identify high-risk patients and enhance pre-operative discussions and optimization.

来源:Surg Endosc,查看原文。版权归原作者所有。

引用

  1. Tran A, Putnam LR, Lipham JC, et al. Utility of the mFI-5 as a predictor of post-operative outcomes following gastrectomy for gastric cancer: an ACS-NSQIP analysis. Surg Endosc. 2024. PMID: 39046494. doi:10.1007/s00464-024-11103-3

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。